Work

Excellent outcomes for patients with B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses

Year: 2019

Type: article

Abstract: The prognosis for children with acute lymphoblastic leukaemia has improved substantially during the past 50 years. The improved survival results from the use of multi-agent, multiblock chemotherapy regimens that have been studied in randomised cooperative group clinical trials. Most gains have occurred in newly diagnosed patients, as the outcome for children with relapsed acute lymphoblastic leukaemia remains relatively poor.

Source: The Lancet Haematology

DOI: 10.1016/s2352-3026(19)30032-8

Author: David T Teachey

Institutions: Children's Hospital of Philadelphia, University of Pennsylvania

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $5,000